Directory
>
Julia Coronella
Julia Coronella
Vice President of Immuno-Oncology | Poseida Therapeutics, Inc.
Carlsbad, California, United States
Julia Coronella
Summary
Julia Coronella is a highly accomplished biotechnology leader with extensive experience in developing innovative biological drugs and building effective teams. Currently serving as Vice President at Poseida Therapeutics, she has a proven track record of achieving significant milestones, including multiple patent filings and IND submissions. Her deep expertise lies in cancer biology, immuno-oncology, and translational pharmacology, making her a key player in advancing therapeutic solutions. Julia's career spans notable roles at organizations like Pfizer and Biogen, where she led critical oncology biologics projects. She is particularly passionate about fostering creativity and collaboration within her teams, which has consistently resulted in high performance. Julia's academic background includes a PhD in Biology from the University of South Florida and a Bachelor's degree from North Carolina State University. Her commitment to understanding complex biological systems is reflected in her scientific approach and leadership style.
Julia Coronella
Work Experience
Vice President of Immuno-Oncology at
Poseida Therapeutics, Inc.
October 2021 - Present
Executive Director of Immuno-Oncology at
Poseida Therapeutics, Inc.
February 2019 - November 2021
Director of Research at
Tanabe Research Laboratories U.S.A., Inc.
February 2013 - December 2018
Principal Scientist at
Pfizer, Inc.
January 2005 - January 2013
Scientist II at
BIOGEN IDEC INDIA
January 2003 - January 2005
Research Assistant Professor at
The University Of Arizona
January 2000 - January 2003
Postdoctoral Fellow at
Harvard University
January 1996 - January 2000
Julia Coronella
Education
North Carolina State University, Bachelor Of Science - Bs
Frequently Asked Questions about Julia Coronella
What is Julia Coronella email address?
Julia Coronella's primary email address is **********@poseida.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Julia Coronella work for?
Julia Coronella is a Vice President of Immuno-Oncology at Poseida Therapeutics, Inc., a company specializing in Commercial physical research.
Where Julia Coronella graduated from?
Julia Coronella holds a degree in Biology from University of South Florida.
How can I directly contact Julia Coronella?
To contact Julia Coronella directly, you can use the email address **********@poseida.com. Complete contact information is available upon registration with Muraena.
Who is Julia Coronella?
Julia Coronella is a highly accomplished biotechnology leader with extensive experience in developing innovative biological drugs and building effective teams. Currently serving as Vice President at Poseida Therapeutics, she has a proven track record of achieving significant milestones, including multiple patent filings and IND submissions. Her deep expertise lies in cancer biology, immuno-oncology, and translational pharmacology, making her a key player in advancing therapeutic solutions. Julia's career spans notable roles at organizations like Pfizer and Biogen, where she led critical oncology biologics projects. She is particularly passionate about fostering creativity and collaboration within her teams, which has consistently resulted in high performance. Julia's academic background includes a PhD in Biology from the University of South Florida and a Bachelor's degree from North Carolina State University. Her commitment to understanding complex biological systems is reflected in her scientific approach and leadership style.
Julia`s contact details
**********@poseida.com
**********@trlusa.com
***************@pfizer.com
Colleagues
Chief Scientific Officer, Gene Therapy
Vice President, Head of Statistical and Data Sciences
General Counsel, Chief Compliance Officer & Corporate Secretary
Vice President, Information Technology
Chief People & Administration Officer
Senior Vice President Regulatory Affairs
Vice President, Cinical Development
Vice President R&D, Gene Therapy
VP, Intellectual Property
Executive Chairman